Literature DB >> 24319585

Hypertension, sweating and palpitation in a psychotic patient - don't miss the somatic cause.

Bidisha Chatterjee1, Cedric Hirzel, Rahel Gerda Sahli.   

Abstract

Entities:  

Year:  2013        PMID: 24319585      PMCID: PMC3831855          DOI: 10.1177/2042533313496087

Source DB:  PubMed          Journal:  JRSM Short Rep        ISSN: 2042-5333


× No keyword cloud information.
With the presentation of this case we want to highlight that even in psychotic patients where elevated blood pressure and palpitations are frequent symptoms, excluding underlying somatic conditions is crucial.

Case report

A 27-year-old man was admitted from prison because of acute psychosis. He was convinced of being part of a conspiracy system, he was not adequate in time and place, but there were no optical or auditory hallucinations. In his medical history there was a fracture of the right fourth finger, there was no positive family history for hypertension or cancer, he was not under any medical treatment, he was jobless and smoked a lot of cannabis. On admission the patient was hypertensive (164/95 mmHg) and had a systolic murmur. Physical examination was otherwise unremarkable. Routine laboratory test was normal. Paliperidone treatment was successfully administered to treat psychosis. He complained about intermittent palpitations and increased sweating during the night. Because of the sinustachycardia and right-sided thoracic pain in combination with elevated d-dimers a pulmonary CT angiogram was performed. No pulmonary embolism was found but a truncated bilateral hypervascular lesion in both adrenal glands. MRI of adrenal glands showed a tumour measuring 3.4 × 3.7 cm on the right side and another one, measuring 1.1 × 1.3 cm on the left side (Figure 1). Further laboratory tests showed no hypercortisolism or hyperaldosteronism, but catecholamine and vanillin mandelic acid (VMA) levels in the 24-h urine sample (noradrenaline 1438 nmol/mmol Cr (reference <75), normetanephrine 3.48 nmol/mmol Cr (reference <0.18), VMA 17.9 µmol/mmolCr (reference <3.0)) were elevated. Chromogranin A was considerably elevated (475 µg/l, reference 19–98 µg/l). Metaiodobenzylguanidine (MIBG) scintigraphy showed an intense tracer uptake in projection to both adrenal glands. No extraadrenal paragangliomas were detected. The genetic testing neither showed mutations in the SDHB or SDHD (succinate dehydrogenase B and D subunits) gene nor the typical mutations for MEN2 (multiple endocrine neoplasia) or von Hippel–Lindau syndrome (VHLS). After medical pretreatment with phenoxybenzamine the patient had total adrenalectomy on the right side and partial adrenalectomy on the left side without pre-, intra- or postoperative hypertensive crisis. He required glucocorticoid substitution, initially administered IV, later on a maintenance dose of fludrocortisones 0.1 mg/day. The diagnosis of a bilateral pheochromocytoma was histologically confirmed. The increased sweating and the palpitations disappeared after the surgery. The psychiatric treatment continued, the patient had regular sessions and continued the neuroleptic and antidepressant drug therapy as well. According to his psychiatrist, one and a half years later his condition is stable. He does not smoke cannabis and is starting a job. To keep his status he does not want to stop the medication at the moment.
Figure 1.

CT scan showing the adrenal tumour on the right side.

CT scan showing the adrenal tumour on the right side.

Discussion

The common symptoms of catecholamine producing tumours are hypertension, episodic headache, sweating and tachycardia.[1] Other symptoms are pallor and less frequently flushing. Psychiatric symptoms such as anxiety, nervousness or panic are also well known,[2] whereas psychosis is not considered as a typical symptom of catecholamine producing tumours. According to our knowledge, there are only three cases in the literature with psychosis as the first manifestation of a pheochromocytoma: in all cases psychotic symptoms disappeared after resection of the tumour without further antipsychotic treatment and did not recur during the follow-up period.[3-5] Although the hormonal link between psychosis and pheochromocytoma remains unclear, there are two well-defined published cases in which the psychosis was healed with resection of the pheochromocytoma. In the present case, the cannabis use in combination with the increased catecholamine levels precipitated psychosis in a vulnerable individual. A review of the literature on pheochromocytomas, published in 2010, reported on 13 cases in the urology department in Spain. In the vast majority of cases (30%) the pheochromocytoma was a so-called incidentaloma.[6] Another review, which was published in 2013, collected data from the Medline database over the last 22 years, and revealed that with a prevalence of 0.1–0.5% of pheochromocytoma in the whole population only half of the cases are diagnosed ante mortem.[7] The diagnosis of pheochromcytoma is difficult to make, first because it is rare and second because the symptoms are not obvious. To diagnose a pheochromocytoma in a patient with atypical symptoms is even more difficult. The review by Koran et al.[8] proved that generally somatic diseases are underdiagnosed in psychiatric patients. The conclusion is that every psychiatric patient needs a somatic work up done.
  8 in total

1.  Relapsing paranoid psychosis as the first manifestation of pheochromocytoma.

Authors:  Antoni Benabarre; Xavier Bosch; Maria T Plana; Albert Lecube; Eduard Vieta; Esteve Cirera; Manuel Valdés
Journal:  J Clin Psychiatry       Date:  2005-07       Impact factor: 4.384

2.  Medical evaluation of psychiatric patients. I. Results in a state mental health system.

Authors:  L M Koran; H C Sox; K I Marton; S Moltzen; C H Sox; H C Kraemer; K Imai; T G Kelsey; T G Rose; L C Levin
Journal:  Arch Gen Psychiatry       Date:  1989-08

3.  Metachronous occurrence of multifocal phaeochromocytoma.

Authors:  Vishesh Jain; Amit Bishnoi; Kanta Meena; Varun Aggarwal; Rajiv Chadha; Archana Puri; Subhasis Roy Choudhury
Journal:  Indian J Pediatr       Date:  2010-12-03       Impact factor: 1.967

4.  Phaeochromocytoma with schizophreniform psychosis.

Authors:  M Bahemuka
Journal:  Br J Psychiatry       Date:  1983-04       Impact factor: 9.319

Review 5.  Recent advances in genetics, diagnosis, localization, and treatment of pheochromocytoma.

Authors:  K Pacak; W M Linehan; G Eisenhofer; M M Walther; D S Goldstein
Journal:  Ann Intern Med       Date:  2001-02-20       Impact factor: 25.391

Review 6.  [Pheochromocytoma: more than a decade of experience. Review of the literature].

Authors:  J A Virseda Rodríguez; J Martínez Ruiz; P Carrión López; C Martínez Sanchiz; M J Donate Moreno; H Pastor Navarro; A Hernández López
Journal:  Actas Urol Esp       Date:  2010-11       Impact factor: 0.994

7.  Pheochromocytoma: recommendations for clinical practice from the First International Symposium. October 2005.

Authors:  Karel Pacak; Graeme Eisenhofer; Håkan Ahlman; Stefan R Bornstein; Anne-Paule Gimenez-Roqueplo; Ashley B Grossman; Noriko Kimura; Massimo Mannelli; Anne Marie McNicol; Arthur S Tischler
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2007-02

8.  Intraoperative management of patients with incidental catecholamine producing tumors: A literature review and analysis.

Authors:  Stefan Hariskov; Roman Schumann
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2013-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.